citalopram hydrobromide · Tablet

What changed in the last 90 days

Every detected change for citalopram hydrobromide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Serotonin Reuptake Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• olanzapine and fuoxetine· 1 maker
• trazodone hydrochloride oral· 1 maker
• escitalopram oral· 2 makers
• fluvoxamine maleate extended-release· 2 makers
• olanzapine and fluoxetine· 2 makers
• nefazodone hydrochloride· 3 makers
• sertraline hcl· 3 makers
• trazodone hcl· 5 makers
• fluoxetine hcl· 6 makers
• sertraline· 13 makers
• paroxetine hydrochloride· 17 makers
• paroxetine hydrochloride hemihydrate· 22 makers

Common questions

Is Citalopram hydrobromide in shortage right now?

No. FDA does not currently list Citalopram hydrobromide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Citalopram hydrobromide?

30 companies have marketed Citalopram hydrobromide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Citalopram hydrobromide cost?

The typical pharmacy pays about $0.0290 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.